Clinical Characteristics and Treatment Outcomes of Mycobacterium fortuitum Pulmonary Disease

We evaluated the clinical characteristics and treatment outcomes of 35 patients diagnosed with Mycobacterium fortuitum-pulmonary disease (M. fortuitum-PD). Prior to treatment, all isolates were sensitive to amikacin and 73% and 90% were sensitive to imipenem and moxifloxacin, respectively. Approxima...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Sae Rom, Yu, Jin Young, Kim, Su-Young, Kim, Dae Hun, Jhun, Byung Woo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2023
Materias:
Observation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433795/
https://www.ncbi.nlm.nih.gov/pubmed/37428038
http://dx.doi.org/10.1128/spectrum.02051-23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433795/
https://www.ncbi.nlm.nih.gov/pubmed/37428038
http://dx.doi.org/10.1128/spectrum.02051-23

Ejemplares similares